Press "Enter" to skip to content

New patent expiration for Abbvie Inc drug TECHNIVIE

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug TECHNIVIE

Annual Drug Patent Expirations for TECHNIVIE
Annual Drug Patent Expirations for TECHNIVIE

Technivie is a drug marketed by Abbvie Inc and is included in one NDA. There are nine patents protecting this drug.

Drug patent litigation for TECHNIVIE.

This drug has three hundred and thirty-four patent family members in forty-five countries.

The generic ingredient in TECHNIVIE is ombitasvir; paritaprevir; ritonavir. Additional details are available on the ombitasvir; paritaprevir; ritonavir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug TECHNIVIE
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions